Time to First and Sustained Improvement in Weekly Migraine Days Among Patients Receiving Preventive Treatment With Rimegepant 75 mg (P9-12.005)

Authors

Institutions

Publication Details

Journal
Neurology
Published
2025-04-07
DOI
https://doi.org/10.1212/wnl.0000000000211168
Primary Topic
Migraine and Headache Studies
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Time to First and Sustained Improvement in Weekly Migraine Days Among Patients Receiving Preventive Treatment With Rimegepant 75 mg (P9-12.005)

Jiyue Yang, Andrew G. Bushmakin, Lucy Abraham, Terence Fullerton et al.
Neurology
Migraine and Headache Studies
article

Time to First and Sustained Improvement in Weekly Migraine Days Among Patients Receiving Preventive Treatment With Rimegepant 75 mg (P9-12.005)

Jiyue Yang, Andrew G. Bushmakin, Lucy Abraham, Terence Fullerton, Stewart J. Tepper, Richard Lipton, Joseph Cappelleri
article en

Abstract

No abstract available for this paper.
NeurologyVol. 104(7_Supplement_1)
Albert Einstein College of Medicine (US), Pfizer (United States) (US), Pfizer (United Kingdom) (GB), New England Institute for Neurology and Headache (US)
Openalex Percentile: Top 91%
Migraine and Headache Studies
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.